Neuromodulation applications for COVID-19 disorders

Latest Updates, and Resources

Share |

What is Long-Covid with Neurological Symptoms?

Mild or moderate COVID-19 usually lasts about two weeks or less for most people. But others experience lingering health problems even when they have recovered from a non-serious initial phase of the illness. In these people, there is no longer an active COVID-19 infection in the sense of a viral load that can be detected or a risk of transmission to others. But, they still experience ongoing symptoms, often debilitating one.

The problem goes by several names. The National Institutes of Health (NIH) terms this long-term COVID-19 symptoms as “post-acute sequelae of SARS-CoV-2” or “PASC” for short. People suffering from these post-COVID symptoms are sometimes known as “long haulers.”

Some individuals develop symptoms following COVID infection that are brain function related. People may report, including:

  • Brain fog
  • Fatigue
  • Headaches
  • Depression
  • Pain
  • Anxiety
  • Sleeping disorders
  • General trouble focusing (brain fog)
  • Cognitive fatigue
  • Dizziness

In some cases, these symptoms resolve on their own with time, or can be treated. But for many people, the symptoms persist and are not easily treatable. This is sometimes also called “Neuro-Covid”.

Scientists now know that even healthy people with mild cases of COVID-19 can battle a constellation of symptoms that appear and even worsen over time, or even sometimes disappear only to come back. These symptoms are all part of what’s called “Long COVID Syndrome.”

Non-invasive Neuromodulation as a potential non-drug treatment for Long-Covid Neurological Symptoms?

Neuromodec previously reviewed Neuromodulation applications for COVID-19 disorders which includes uses in the acute and long-term stages. But with the growing and evolving situation with COVID Long-Haulers reporting trouble focusing, cognitive fatigue and other issues, Neuromodec will provide ongoing updates on research and development of drug-free non-invasive neuromodulation options for long-COVID.

Latest Updates

Update 2
NYU Langone launches an entirely
home-based telemedicine neuromodulation treatment for a range of neurological disorders including Long-Covid. This treatment is based around transcranial Direct Current Stimulation. You can learn more and access treatment here.
Published on: May 30th, 2021

Update 1
Medical University of South Caroline and
Soterix Medical announce a new clinical trial of home-based auricular Vagus Nerve Stimulation (taVNS) for individuals who experience post-COVID neuropsychiatric symptoms, like fatigue, headache, or anxiety. Mark George, a leader in neuromodulation and co-leader of the trial says “When your body tries to fight off COVID… an inflammatory cascade that can kick in… A lot of people feel that the inflammation is what’s causing those symptoms to occur post-COVID. If we can reduce inflammation [with taVNS neuromodulation], we have a chance of reducing that.” Learn more and sign up here
Published on: November 16, 2020

Find top tDCS doctors in your area

Neuromodec offers a free unbiased search tool that helps connect patients with top tDCS specialists in their area

Subscribe to stay up to date about the latest in Neuromodulation